Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it

摘要

Crystalline form III of the compound of formula (I): characterized by its powder X-ray diffraction diagram. Medicinal products containing the same which are useful in the treatment of melatoninergic disorders.